Dose-Expansion Study Of Trastuzumab Deruxtecan As Monotherapy Or Combined With Pertuzumab In Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive (Her2+) Breast Cancer In Destiny-Breast07 (Db-07)
Trastuzumab Deruxtecan;Pertuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dose-Expansion Study Of Trastuzumab Deruxtecan As Monotherapy Or Combined With Pertuzumab In Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive (Her2+) Breast Cancer In Destiny-Breast07 (Db-07) ### Output: Trastuzumab Deruxtecan;Pertuzumab